% | $
Quotes you view appear here for quick access.

MiMedx Group, Inc. Message Board

jpdgrisgris 2 posts  |  Last Activity: Aug 21, 2015 9:28 AM Member since: Sep 14, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • jpdgrisgris by jpdgrisgris Aug 21, 2015 9:28 AM Flag

    Curious to know what Louis thinks about his $15 end of year target?

    Sentiment: Buy

  • Reply to

    time to talk turkey

    by how_bout_we_talk Aug 15, 2015 12:45 PM
    jpdgrisgris jpdgrisgris Aug 16, 2015 6:30 PM Flag

    I seldom blog here for a variety of reasons. But sometimes one just has to chime in, like now, because the crazies have taken over the asylum. The irrationality of the comments over the past two weeks demands a reality check.

    Mimedex was fortunate to be added to the Small Cap S&P 600 Biotechnological Index in July. For those of you who don't know, this is a very, very prestigious event. And for damn sure it is very seldom accomplished by a company with only four or five years in the market. What does being added to the Index mean in the short and in the long term? It means that Mimedex will follow very closely the moves, both up and down of this index. These moves, both up and down, may have nothing to do with the actually company. For example, the the total biological sector has been out of favor the last several weeks. It would be NORMAL for that to turn around because the sector is not down due to economic news. It should pop back soon: very soon. Moreover, there was a lot of re-balancing that had to be done when Mimedex was added to the 600. Remember, most of these guys don't know Mimedex, so sell orders were placed because "moving averages" were breached. Once again, in a short period of time this should correct itself.

    The Shorts. The shorts generally make their plays not on numbers but on rumors and innuendo: and index movements. When an index fails out of favor, take a look at the short action. As in our case, the shorts benefited from the double whammy: the addition of Mimedex to the 600 and the re-balancing that occurred after our entry in July and the biotechnology index falling our of favor.

    Within a couple of weeks the shorts will be gone and the stock price will pop back up to where it should be.

    The negative comments posted on this board are mostly silly arguments. They are either driven by people who probably should not be investing or by the shorts. Only a fool would play Mimedex as a short

    Sentiment: Strong Buy

9.60+0.12(+1.27%)Aug 28 4:00 PMEDT